Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers
The multifaceted role of extracellular vesicles in prostate cancer-a review
The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma
A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer
Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
New mechanisms of multidrug resistance: an introduction to the <i>Cancer Drug Resistance</i> special collection
Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7
Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment
Emerging resistance <i>vs.</i> losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena
A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia